Proteomic Phenotyping of Stimulated Müller Cells Uncovers Profound Pro-Inflammatory Signaling and Antigen-Presenting Capacity.

Müller cells atypical antigen-presenting cell complement system cytokines diabetic retinopathy immune response oxidative phosphorylation retina

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2021
Historique:
received: 06 09 2021
accepted: 12 10 2021
entrez: 15 11 2021
pubmed: 16 11 2021
medline: 16 11 2021
Statut: epublish

Résumé

Müller cells are the main macroglial cells of the retina exerting a wealth of functions to maintain retinal homoeostasis. Upon pathological changes in the retina, they become gliotic with both protective and detrimental consequences. Accumulating data also provide evidence for a pivotal role of Müller cells in the pathogenesis of diabetic retinopathy (DR). While microglial cells, the resident immune cells of the retina are considered as main players in inflammatory processes associated with DR, the implication of activated Müller cells in chronic retinal inflammation remains to be elucidated. In order to assess the signaling capacity of Müller cells and their role in retinal inflammation, we performed in-depth proteomic analysis of Müller cell proteomes and secretomes after stimulation with INFγ, TNFα, IL-4, IL-6, IL-10, VEGF, TGFβ1, TGFβ2 and TGFβ3. We used both, primary porcine Müller cells and the human Müller cell line MIO-M1 for our hypothesis generating approach. Our results point towards an intense signaling capacity of Müller cells, which reacted in a highly discriminating manner upon treatment with different cytokines. Stimulation of Müller cells resulted in a primarily pro-inflammatory phenotype with secretion of cytokines and components of the complement system. Furthermore, we observed evidence for mitochondrial dysfunction, implying oxidative stress after treatment with the various cytokines. Finally, both MIO-M1 cells and primary porcine Müller cells showed several characteristics of atypical antigen-presenting cells, as they are capable of inducing MHC class I and MHC class II with co-stimulatory molecules. In line with this, they express proteins associated with formation and maturation of phagosomes. Thus, our findings underline the importance of Müller cell signaling in the inflamed retina, indicating an active role in chronic retinal inflammation.

Identifiants

pubmed: 34776983
doi: 10.3389/fphar.2021.771571
pii: 771571
pmc: PMC8585775
doi:

Types de publication

Journal Article

Langues

eng

Pagination

771571

Informations de copyright

Copyright © 2021 Schmalen, Lorenz, Grosche, Pauly, Deeg and Hauck.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Invest Ophthalmol Vis Sci. 2005 Feb;46(2):568-78
pubmed: 15671284
Trends Neurosci. 1996 Aug;19(8):307-12
pubmed: 8843598
Am J Pathol. 2012 Aug;181(2):719-27
pubmed: 22677420
Elife. 2018 Aug 03;7:
pubmed: 30074479
Prog Retin Eye Res. 2017 Jul;59:53-96
pubmed: 28363849
J Neuroinflammation. 2011 Dec 07;8:173
pubmed: 22152278
Prog Retin Eye Res. 2015 Mar;45:30-57
pubmed: 25476242
J Proteome Res. 2014 Mar 7;13(3):1234-47
pubmed: 24512137
J Proteomics. 2021 Jan 6;230:103989
pubmed: 32977044
Nature. 1997 Feb 13;385(6617):640-4
pubmed: 9024663
J Anat. 2017 Oct;231(4):471-483
pubmed: 28695619
J Immunol. 2012 Nov 1;189(9):4213-9
pubmed: 23087426
J Neuroinflammation. 2019 Jul 8;16(1):138
pubmed: 31286987
Am J Respir Cell Mol Biol. 2021 Oct;65(4):430-441
pubmed: 34038697
Diabetologia. 2017 Aug;60(8):1541-1549
pubmed: 28480495
J Biol Chem. 1994 Oct 28;269(43):26783-8
pubmed: 7929414
Mol Vis. 2011;17:2738-50
pubmed: 22065927
Neural Regen Res. 2018 Nov;13(11):1861-1870
pubmed: 30233053
Mol Vis. 2011;17:1745-58
pubmed: 21738403
J Cell Biol. 1993 Aug;122(4):923-32
pubmed: 8349738
Front Neurosci. 2018 Dec 03;12:890
pubmed: 30559643
Mol Vis. 2020 Oct 15;26:718-721
pubmed: 33209014
Prog Retin Eye Res. 2006 Jul;25(4):397-424
pubmed: 16839797
Diabetes. 2010 Sep;59(9):2297-305
pubmed: 20530741
Nat Rev Immunol. 2014 Nov;14(11):719-30
pubmed: 25324123
Cell. 2020 Sep 17;182(6):1623-1640.e34
pubmed: 32946783
Front Immunol. 2019 Jul 16;10:1618
pubmed: 31379825
Biochem Biophys Res Commun. 2021 Jul 5;561:143-150
pubmed: 34023779
Front Physiol. 2018 Sep 05;9:1268
pubmed: 30233418
Free Radic Biol Med. 2015 Sep;86:25-36
pubmed: 25920363
Exp Eye Res. 2011 Jan;92(1):87-93
pubmed: 21111734
Vision Res. 2017 Oct;139:93-100
pubmed: 28866025
Trends Immunol. 2001 Mar;22(3):141-8
pubmed: 11286729
Immunology. 2003 Oct;110(2):163-9
pubmed: 14511229
Invest Ophthalmol Vis Sci. 2004 Feb;45(2):515-21
pubmed: 14744893
Diabetologia. 2014 Oct;57(10):2222-31
pubmed: 25015056
J Neuroinflammation. 2015 Jan 17;12:8
pubmed: 25595590
Biochemistry. 2014 Sep 16;53(36):5737-49
pubmed: 25153513
J Dev Biol. 2016 Jun 22;4(2):
pubmed: 29615587
PeerJ. 2021 May 18;9:e11316
pubmed: 34046254
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
J Neuroinflammation. 2014 Feb 18;11:33
pubmed: 24548736
Bioinformatics. 2004 Nov 22;20(17):3246-8
pubmed: 15180930
Diabetes. 1998 Mar;47(3):445-9
pubmed: 9519752
J Pathol. 2009 Dec;219(4):446-54
pubmed: 19768732
Proteomics. 2012 Jun;12(12):1902-11
pubmed: 22623344
J Ocul Pharmacol Ther. 2015 Sep;31(7):371-5
pubmed: 26352161
Int J Mol Sci. 2021 Feb 20;22(4):
pubmed: 33672611
Nat Methods. 2007 Nov;4(11):923-5
pubmed: 17952086
Cell Mol Neurobiol. 2021 Jan;41(1):43-62
pubmed: 32219603
Front Immunol. 2020 Nov 06;11:564077
pubmed: 33240260
J Anim Physiol Anim Nutr (Berl). 2012 Apr;96(2):260-9
pubmed: 21535230
Glycobiology. 2021 Aug 7;31(7):873-883
pubmed: 33677598
Stem Cells. 2007 Aug;25(8):2033-43
pubmed: 17525239
J Immunol. 2002 Mar 1;168(5):2456-63
pubmed: 11859138
Behav Brain Res. 2001 Nov 1;125(1-2):279-84
pubmed: 11682119
Exp Eye Res. 1991 Nov;53(5):603-7
pubmed: 1743259
Graefes Arch Clin Exp Ophthalmol. 2020 Feb;258(2):221-230
pubmed: 31734719
FASEB J. 2006 Feb;20(2):323-5
pubmed: 16368716
Invest Ophthalmol Vis Sci. 2002 Mar;43(3):864-9
pubmed: 11867609
Mol Neurodegener. 2017 Apr 24;12(1):31
pubmed: 28438165
J Ophthalmol. 2017;2017:9402198
pubmed: 28680705
Transl Vis Sci Technol. 2018 Jul 18;7(4):6
pubmed: 30034950
Invest Ophthalmol Vis Sci. 2017 Jun 1;58(7):2915-2921
pubmed: 28586916
Mol Cell Proteomics. 2016 Feb;15(2):462-80
pubmed: 26324419
Eur J Neurosci. 2018 Jun;47(12):1429-1443
pubmed: 29790615
FASEB J. 2019 Mar;33(3):3680-3692
pubmed: 30462532
J Immunol. 1988 Apr 1;140(7):2193-6
pubmed: 2965182
J Leukoc Biol. 2012 Oct;92(4):753-64
pubmed: 22782966
Glia. 2020 Apr;68(4):768-796
pubmed: 31793693
Prog Retin Eye Res. 2009 Nov;28(6):423-51
pubmed: 19660572
Eye (Lond). 2006 Dec;20(12):1366-9
pubmed: 16284605
J Ophthalmol. 2015;2015:605946
pubmed: 25821590
Pharmacol Res. 2015 Sep;99:137-48
pubmed: 26054568
Glia. 2016 Apr;64(4):495-506
pubmed: 26556395
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8
pubmed: 9843981
Vision Res. 2017 Oct;139:7-14
pubmed: 28412095
Nat Commun. 2019 Feb 14;10(1):755
pubmed: 30765703
Invest Ophthalmol Vis Sci. 2005 Jan;46(1):349-57
pubmed: 15623795
Curr Eye Res. 2019 May;44(5):564-574
pubmed: 30644770
Cells. 2021 Mar 23;10(3):
pubmed: 33806940
Nat Rev Immunol. 2015 Apr;15(4):203-16
pubmed: 25720354
Cell. 1997 Nov 14;91(4):521-30
pubmed: 9390561
Dev Comp Immunol. 2009 Mar;33(3):362-74
pubmed: 18760302
PLoS One. 2008;3(10):e3381
pubmed: 18852882
Cell Rep. 2019 Nov 26;29(9):2835-2848.e4
pubmed: 31775049
Glia. 2003 Dec;44(3):251-63
pubmed: 14603466
Exp Eye Res. 1994 Dec;59(6):723-7
pubmed: 7698265
Proteomics. 2018 Jun;18(11):e1700321
pubmed: 29645351
Nat Methods. 2009 May;6(5):359-62
pubmed: 19377485
J Proteome Res. 2007 Jun;6(6):2121-31
pubmed: 17444670
Cell Tissue Res. 2020 May;380(2):341-378
pubmed: 31932949
Front Immunol. 2020 Nov 06;11:583687
pubmed: 33240272
Exp Eye Res. 2011 Aug;93(2):165-9
pubmed: 20708611
Arch Ophthalmol. 2008 Feb;126(2):227-32
pubmed: 18268214
Curr Eye Res. 2001 May;22(5):341-7
pubmed: 11600934
Nat Immunol. 2015 Nov;16(11):1142-52
pubmed: 26414765
Anat Rec (Hoboken). 2009 Dec;292(12):1902-13
pubmed: 19943344
Invest Ophthalmol Vis Sci. 2020 Mar 9;61(3):47
pubmed: 32232352
Lancet Glob Health. 2021 Feb;9(2):e144-e160
pubmed: 33275949
Mol Cell Proteomics. 2014 Sep;13(9):2371-81
pubmed: 24925906
Biochem Biophys Res Commun. 2019 Sep 17;517(2):227-232
pubmed: 31331642
Diabetes. 2012 Feb;61(2):492-504
pubmed: 22228718
Vet Clin North Am Food Anim Pract. 2010 Nov;26(3):557-72
pubmed: 21056801
Front Immunol. 2015 Jul 17;6:363
pubmed: 26236315
Exp Cell Res. 2015 Feb 1;331(1):223-231
pubmed: 25239226
Cell Tissue Res. 2012 Jan;347(1):279-90
pubmed: 22101332
Mol Cell Proteomics. 2008 Jul;7(7):1349-61
pubmed: 18436526
J Diabetes Res. 2019 Aug 14;2019:8562408
pubmed: 31511825
Lab Invest. 2010 Sep;90(9):1365-72
pubmed: 20479714
Blood. 1996 Feb 15;87(4):1439-45
pubmed: 8608234

Auteurs

Adrian Schmalen (A)

Research Unit Protein Science and Metabolomics and Proteomics Core, Helmholtz Center Munich, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
Chair of Physiology, Department of Veterinary Sciences, LMU Munich, Martinsried, Germany.

Lea Lorenz (L)

Chair of Physiology, Department of Veterinary Sciences, LMU Munich, Martinsried, Germany.

Antje Grosche (A)

Department of Physiological Genomics, Biomedical Center, LMU Munich, Martinsried, Germany.

Diana Pauly (D)

Experimental Ophthalmology, Philipps-University Marburg, Marburg, Germany.
Department of Ophthalmology, University Hospital Regensburg, Regensburg, Germany.

Cornelia A Deeg (CA)

Chair of Physiology, Department of Veterinary Sciences, LMU Munich, Martinsried, Germany.

Stefanie M Hauck (SM)

Research Unit Protein Science and Metabolomics and Proteomics Core, Helmholtz Center Munich, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.

Classifications MeSH